does semaglutide affect estrogen and Menopause: It Work? Can Semaglutide Cause irregular Periods

Liraglutide effects on glycemic control and weight in patients with type 2 diabetes Mellitus: A real-world, observational study and brief narrative review

Source: Employer Benefit Research Institute April 16, 2026 GLP-1 medications for obesity carry a well-documented discontinuation problem, and stopping them typically means regaining weight and the return of cardiometabolic risk factors

The logic was straightforward, the clinical use widespread, and the benefits, at least for symptom management, well established

Measuring cerebral and cerebellar glutathione in children using (1)H MEGA-PRESS MRS

Preclinical studies in diet-induced obese (DIO) mice showed that once-weekly administration of the PEGylated GLP-1R/GcgR co-agonist for 1 month dramatically lowered body weight, compared with vehicle treatment [17]

doi: 10.1016/j.freeradbiomed.2018.06.015